99 related articles for article (PubMed ID: 8082575)
1. Biochemical individuality and its implications for drug and carcinogen metabolism: recent insights from acetyltransferase and cytochrome P4501A2 phenotyping and genotyping in humans.
Kadlubar FF
Drug Metab Rev; 1994; 26(1-2):37-46. PubMed ID: 8082575
[No Abstract] [Full Text] [Related]
2. Aromatic and heterocyclic amine metabolism and phenotyping in humans.
Lang NP; Kadlubar FF
Prog Clin Biol Res; 1991; 372():33-47. PubMed ID: 1956928
[TBL] [Abstract][Full Text] [Related]
3. Bioactivation of aromatic amines by recombinant human cytochrome P4501A2 expressed in Ames tester strain bacteria: a substitute for activation by mammalian tissue preparations.
Josephy PD; DeBruin LS; Lord HL; Oak JN; Evans DH; Guo Z; Dong MS; Guengerich FP
Cancer Res; 1995 Feb; 55(4):799-802. PubMed ID: 7850792
[TBL] [Abstract][Full Text] [Related]
4. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps.
Lang NP; Butler MA; Massengill J; Lawson M; Stotts RC; Hauer-Jensen M; Kadlubar FF
Cancer Epidemiol Biomarkers Prev; 1994 Dec; 3(8):675-82. PubMed ID: 7881341
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
Badawi AF; Stern SJ; Lang NP; Kadlubar FF
Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
[TBL] [Abstract][Full Text] [Related]
6. Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities.
McQuilkin SH; Nierenberg DW; Bresnick E
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):139-46. PubMed ID: 7742721
[TBL] [Abstract][Full Text] [Related]
7. Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity.
Eaton DL; Gallagher EP; Bammler TK; Kunze KL
Pharmacogenetics; 1995 Oct; 5(5):259-74. PubMed ID: 8563766
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
Raza H; King RS; Squires RB; Guengerich FP; Miller DW; Freeman JP; Lang NP; Kadlubar FF
Drug Metab Dispos; 1996 Apr; 24(4):395-400. PubMed ID: 8801053
[TBL] [Abstract][Full Text] [Related]
9. Carcinogenic aromatic amine metabolism and DNA adduct detection in humans.
Kadlubar FF
Princess Takamatsu Symp; 1990; 21():329-38. PubMed ID: 2134686
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic drug metabolism: studies with recombinant Chinese hamster cells and analyses in human populations.
Yokoi T; Sawada M; Kamataki T
Pharmacogenetics; 1995; 5 Spec No():S65-9. PubMed ID: 7581492
[TBL] [Abstract][Full Text] [Related]
11. Human cytochrome P4501A2.
Landi MT; Sinha R; Lang NP; Kadlubar FF
IARC Sci Publ; 1999; (148):173-95. PubMed ID: 10493258
[TBL] [Abstract][Full Text] [Related]
12. [Genetic polymorphism of the hepatic metabolism of drugs].
Larrey D; Pessayre D; Benhamou JP
Gastroenterol Clin Biol; 1985; 9(6-7):522-31. PubMed ID: 3926587
[No Abstract] [Full Text] [Related]
13. Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis.
Kadlubar FF; Butler MA; Kaderlik KR; Chou HC; Lang NP
Environ Health Perspect; 1992 Nov; 98():69-74. PubMed ID: 1486865
[TBL] [Abstract][Full Text] [Related]
14. Acetylator status, drug metabolism and disease.
Pande JN; Pande A; Singh SP
Natl Med J India; 2003; 16(1):24-6. PubMed ID: 12715953
[TBL] [Abstract][Full Text] [Related]
15. Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene.
Nakajima M; Yokoi T; Mizutani M; Shin S; Kadlubar FF; Kamataki T
Cancer Epidemiol Biomarkers Prev; 1994; 3(5):413-21. PubMed ID: 7920209
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
18. Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment.
Mathijssen RH; van Schaik RH
Eur J Cancer; 2006 Jan; 42(2):141-8. PubMed ID: 16325399
[TBL] [Abstract][Full Text] [Related]
19. Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
Sikka R; Magauran B; Ulrich A; Shannon M
Acad Emerg Med; 2005 Dec; 12(12):1227-35. PubMed ID: 16282513
[TBL] [Abstract][Full Text] [Related]
20. Determination of carcinogenic arylamine N-oxidation phenotype in humans by analysis of caffeine urinary metabolites.
Kadlubar FF; Talaska G; Butler MA; Teitel CH; Massengill JP; Lang NP
Prog Clin Biol Res; 1990; 340B():107-14. PubMed ID: 2392442
[No Abstract] [Full Text] [Related]
[Next] [New Search]
